UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

New blood biomarkers and imaging for disease stratification and monitoring of giant cell arteritis

Rheumatic & musculoskeletal diseases open, 2024-02, Vol.10 (1), p.e003397

2024

Volltextzugriff (PDF)

Spontaneous Coronary-Artery Dissection

The New England journal of medicine, 2021-03, Vol.384 (11), p.1077-1078

2021

Volltextzugriff (PDF)

The target on B cells in Systemic Sclerosis: a “midsummer dream” to extinguish inflammation and prevent early disease progression to fibrosis

Clinical rheumatology, 2021-07, Vol.40 (7), p.2529-2533

2021

Volltextzugriff (PDF)

Looking ahead: giant-cell arteritis in 10 years time

Therapeutic Advances in Musculoskeletal Disease, 2022, Vol.14, p.1759720X221096366-1759720X221096366

2022

Volltextzugriff (PDF)

Interleukin-1 and Systemic Sclerosis: Getting to the Heart of Cardiac Involvement

Frontiers in immunology, 2021-03, Vol.12, p.653950-653950

2021

Volltextzugriff (PDF)

Efficacy of canakinumab as first-line biologic agent in adult-onset Still's disease

Arthritis research & therapy, 2019-02, Vol.21 (1), p.54-54, Article 54

2019

Volltextzugriff (PDF)

Subclinical giant cell arteritis in new onset polymyalgia rheumatica A systematic review and meta-analysis of individual patient data

Seminars in arthritis and rheumatism, 2022-08, Vol.55, p.152017, Article 152017

2022

Volltextzugriff (PDF)

Large-vessel Vasculitis Affecting the Aorta and its Branches in Relapsing Polychondritis: Case Series and Systematic Review of the Literature

Journal of rheumatology, 2020-12, Vol.47 (12), p.1780-1784

2020

Volltextzugriff (PDF)

Repurposing of Biologic and Targeted Synthetic Anti-Rheumatic Drugs in COVID-19 and Hyper-Inflammation: A Comprehensive Review of Available and Emerging Evidence at the Peak of the Pandemic

Frontiers in pharmacology, 2020-12, Vol.11, p.598308-598308

2020

Volltextzugriff (PDF)

Respiratory Impairment Predicts Response to IL-1 and IL-6 Blockade in COVID-19 Patients With Severe Pneumonia and Hyper-Inflammation

Frontiers in immunology, 2021-04, Vol.12, p.675678

2021

Volltextzugriff (PDF)

Treating Heart Inflammation With Interleukin-1 Blockade in a Case of Erdheim-Chester Disease

Frontiers in immunology, 2018-06, Vol.9, p.1233-1233

2018

Volltextzugriff (PDF)

Cardiovascular involvement in Erdheim–Chester diseases is associated with myocardial fibrosis and atrial dysfunction

Radiologia medica, 2023-04, Vol.128 (4), p.456-466

2023

Volltextzugriff (PDF)

Effectiveness and safety of infliximab dose escalation in patients with refractory Takayasu arteritis: A real-life experience from a monocentric cohort

Modern rheumatology, 2022-02, Vol.32 (2), p.406-412

2022

Volltextzugriff (PDF)

Case report: Cytopenias in VEXAS syndrome - a WHO 2022 based approach in a single-center cohort

Frontiers in immunology, 2024-01, Vol.15, p.1354130

2024

Volltextzugriff (PDF)

Correction to: Efficacy of canakinumab as first-line biologic agent in adult-onset Still's disease

Arthritis research & therapy, 2019-02, Vol.21 (1), p.69-69, Article 69

2019

Volltextzugriff (PDF)

Tocilizumab in patients with multisystem Erdheim-Chester disease

Oncoimmunology, 2017-06, Vol.6 (6), p.e1318237-e1318237

2017

Volltextzugriff (PDF)

The fibrogenic chemokine CCL18 is associated with disease severity in Erdheim-Chester disease

Oncoimmunology, 2018-01, Vol.7 (7), p.e1440929-e1440929

2018

Volltextzugriff (PDF)

Impact of Geographic Location on Diagnosis and Initial Management of Takayasu Arteritis: A Tale of Two Cohorts from Italy and India

Diagnostics (Basel), 2022-12, Vol.12 (12), p.3102

2022

Volltextzugriff (PDF)

A Prospective Observational Study on the Efficacy and Safety of Infliximab-Biosimilar (CT-P13) in Patients With Takayasu Arteritis (TAKASIM)

Frontiers in medicine, 2021-09, Vol.8, p.723506-723506

2021

Volltextzugriff (PDF)

PB2199: GEOGRAPHIC CLUSTERING OF ERDHEIM‐CHESTER DISEASE IN ITALY AND FRANCE

HemaSphere, 2023-08, Vol.7 (S3), p.e512316e-n/a

2023

Volltextzugriff (PDF)

Response to ‘Correspondence on ‘Impact of COVID-19 pandemic on patients with large-vessels vasculitis in Italy: a monocentric survey’’ by Montero et al

Annals of the rheumatic diseases, 2023-07, Vol.82 (7), p.e156-e156

2023

Volltextzugriff (PDF)

Potential acceptance of COVID-19 vaccine in rheumatological patients: a monocentric comparative survey

Annals of the rheumatic diseases, 2021-06, Vol.80 (6), p.816-817

2021

Volltextzugriff (PDF)

Impact of COVID-19 pandemic on patients with large-vessel vasculitis in Italy: a monocentric survey

Annals of the rheumatic diseases, 2020-09, Vol.79 (9), p.1252-1253

2020

Volltextzugriff (PDF)

Comment on: Diagnostic accuracy of ultrasound for detecting large-vessel giant cell arteritis using FDG PET/CT as the reference

Rheumatology (Oxford, England), 2021-02, Vol.60 (2), p.e66-e66

2021

Volltextzugriff (PDF)

Successful use of ixekizumab for glucocorticoid-free remission maintenance in giant cell arteritis

Rheumatology (Oxford, England), 2023-02, Vol.62 (2), p.e24-e26

2023

Volltextzugriff (PDF)

1 – 25 von 168

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(160)
Mit Volltextzugriff
(130)

Publikationsform

Artikel
(164)
Berichte
(4)

Sprache

Englisch
(168)
Japanisch
(13)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)
... seit 90 Tagen
(3)

Menü

Weitere Dienste

Einstellungen

New blood biomarkers and imaging for disease stratification and monitoring of giant cell arteritis

Spontaneous Coronary-Artery Dissection

The target on B cells in Systemic Sclerosis: a “midsummer dream” to extinguish inflammation and prevent early disease progression to fibrosis

Looking ahead: giant-cell arteritis in 10 years time

Interleukin-1 and Systemic Sclerosis: Getting to the Heart of Cardiac Involvement

Efficacy of canakinumab as first-line biologic agent in adult-onset Still's disease

Subclinical giant cell arteritis in new onset polymyalgia rheumatica A systematic review and meta-analysis of individual patient data

Large-vessel Vasculitis Affecting the Aorta and its Branches in Relapsing Polychondritis: Case Series and Systematic Review of the Literature

Repurposing of Biologic and Targeted Synthetic Anti-Rheumatic Drugs in COVID-19 and Hyper-Inflammation: A Comprehensive Review of Available and Emerging Evidence at the Peak of the Pandemic

Respiratory Impairment Predicts Response to IL-1 and IL-6 Blockade in COVID-19 Patients With Severe Pneumonia and Hyper-Inflammation

Treating Heart Inflammation With Interleukin-1 Blockade in a Case of Erdheim-Chester Disease

Cardiovascular involvement in Erdheim–Chester diseases is associated with myocardial fibrosis and atrial dysfunction

Effectiveness and safety of infliximab dose escalation in patients with refractory Takayasu arteritis: A real-life experience from a monocentric cohort

Case report: Cytopenias in VEXAS syndrome - a WHO 2022 based approach in a single-center cohort

Correction to: Efficacy of canakinumab as first-line biologic agent in adult-onset Still's disease

Tocilizumab in patients with multisystem Erdheim-Chester disease

The fibrogenic chemokine CCL18 is associated with disease severity in Erdheim-Chester disease

Impact of Geographic Location on Diagnosis and Initial Management of Takayasu Arteritis: A Tale of Two Cohorts from Italy and India

A Prospective Observational Study on the Efficacy and Safety of Infliximab-Biosimilar (CT-P13) in Patients With Takayasu Arteritis (TAKASIM)

PB2199: GEOGRAPHIC CLUSTERING OF ERDHEIM‐CHESTER DISEASE IN ITALY AND FRANCE

Response to ‘Correspondence on ‘Impact of COVID-19 pandemic on patients with large-vessels vasculitis in Italy: a monocentric survey’’ by Montero et al

Potential acceptance of COVID-19 vaccine in rheumatological patients: a monocentric comparative survey

Impact of COVID-19 pandemic on patients with large-vessel vasculitis in Italy: a monocentric survey

Comment on: Diagnostic accuracy of ultrasound for detecting large-vessel giant cell arteritis using FDG PET/CT as the reference

Successful use of ixekizumab for glucocorticoid-free remission maintenance in giant cell arteritis

Suchergebnisse filtern